Valiant Organics Ltd

Valiant Organics Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Valiant Organics Ltd

₹ 453 -3.00%
16 Jun 2:29 p.m.
valiantorganics.com BSE: 540145 NSE: VALIANTORG
About

Incorporated in 1984, Valiant Organics
Ltd manufactures and deals in specialty chemicals and pharma intermediates[1]

Key Points

Business Overview:[1][2][3]
VOL is is promoted by Gogri, Chedda and Gala families. It manufactures specialty chemicals and is one of the largest manufacturers of chlorophenol derivatives, Benzene derivatives, PNA, PAP, Ortho Anisidine and Para Anisidine.

Product Portfolio[4]
1. Ammonolysis
Products include Para Nitro Aniline and Ortho Chloro Para Nitro Aniline, primarily serving the dyes and pigments industries.

2. Hydrogenation
The product range comprises Ortho Anisidine, Para Anisidine, IPPCA, Meta Chloro Aniline, Para Amino Phenol, and Ortho Amino Phenol, catering to dyes, pigments, pharmaceuticals, and agrochemicals sectors.

3. Chlorination
Key products are Para ChloroPhenol (PCP), Ortho ChloroPhenol (OCP), 2,4 Di ChloroPhenol (2,4 DCP), 2,6 Di ChloroPhenol (2,6 DCP), and 2,4,6 Tri ChloroPhenol (2,4,6 TCP), widely used in agrochemicals, cosmetics, veterinary, and pharmaceutical applications.

Website BSE NSE
  • Market Cap ₹ 1,268 Cr.
  • Current Price ₹ 453
  • High / Low ₹ 508 / 225
  • Stock P/E
  • Book Value ₹ 259
  • Dividend Yield 0.00 %
  • ROCE 2.63 %
  • ROE -0.47 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 1.27% over past five years.
  • Company has a low return on equity of 3.59% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
347.62 265.96 264.07 250.37 271.40 201.84 203.10 141.36 176.76 167.92 160.18 186.86 203.81
290.63 234.08 222.18 212.18 219.14 177.98 187.61 138.78 178.94 152.38 159.44 171.54 183.53
Operating Profit 56.99 31.88 41.89 38.19 52.26 23.86 15.49 2.58 -2.18 15.54 0.74 15.32 20.28
OPM % 16.39% 11.99% 15.86% 15.25% 19.26% 11.82% 7.63% 1.83% -1.23% 9.25% 0.46% 8.20% 9.95%
2.25 1.92 1.88 6.35 2.79 8.96 3.63 0.40 -7.10 0.38 2.53 5.85 0.91
Interest 1.72 2.73 2.51 2.59 2.97 4.31 3.82 4.19 7.09 4.91 8.25 5.83 4.65
Depreciation 8.39 6.78 7.16 7.27 7.98 8.67 8.89 8.60 8.77 8.78 8.79 8.99 9.20
Profit before tax 49.13 24.29 34.10 34.68 44.10 19.84 6.41 -9.81 -25.14 2.23 -13.77 6.35 7.34
Tax % 24.55% 30.34% 25.04% 24.83% 22.90% 24.75% 25.90% -19.57% -19.69% 127.80% -9.44% 14.02% 42.78%
37.07 16.92 25.56 26.08 34.00 14.93 4.75 -7.89 -20.19 -0.62 -12.47 5.46 4.20
EPS in Rs 11.45 5.68 7.72 8.09 10.96 4.57 1.58 -2.86 -7.32 -0.22 -4.63 1.98 1.50
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
692 675 755 1,153 1,052 723 719
511 494 550 948 888 686 666
Operating Profit 181 181 205 205 164 37 53
OPM % 26% 27% 27% 18% 16% 5% 7%
8 6 6 7 13 6 9
Interest 4 3 5 6 11 16 24
Depreciation 14 16 21 30 29 35 36
Profit before tax 171 168 185 176 137 -9 2
Tax % 29% 25% 29% 27% 25% -3% 260%
121 126 131 128 103 -8 -3
EPS in Rs 103.65 51.00 42.19 41.72 32.45 -3.04 -1.34
Dividend Payout % 6% 11% 12% 8% 3% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 1%
3 Years: -15%
TTM: -1%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 47%
Stock Price CAGR
10 Years: %
5 Years: -10%
3 Years: -4%
1 Year: 13%
Return on Equity
10 Years: %
5 Years: 10%
3 Years: 4%
Last Year: 0%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 6 12 27 27 27 28 28
Reserves 254 374 475 586 662 702 697
77 140 210 364 274 257 249
112 143 165 216 276 262 209
Total Liabilities 448 669 876 1,192 1,239 1,248 1,183
150 276 510 543 670 643 657
CWIP 66 129 46 112 71 86 66
Investments 12 23 6 8 41 99 94
221 241 314 529 457 420 367
Total Assets 448 669 876 1,192 1,239 1,248 1,183

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
76 161 115 -31 238 84 56
-86 -184 -159 -124 -143 -65 -21
1 27 49 167 -112 -23 -32
Net Cash Flow -9 5 5 12 -17 -4 4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 75 72 76 102 88 106 90
Inventory Days 44 42 66 54 68 88 71
Days Payable 69 82 97 63 89 159 119
Cash Conversion Cycle 50 32 44 93 67 34 42
Working Capital Days 63 42 63 103 81 88 90
ROCE % 39% 30% 21% 14% 1% 3%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
38.46% 38.43% 38.41% 38.41% 38.37% 37.90% 37.90% 37.77% 37.77% 37.77% 37.73% 37.91%
1.99% 0.68% 0.57% 0.18% 0.30% 0.19% 0.69% 1.14% 1.35% 1.34% 0.82% 0.37%
1.89% 2.13% 1.94% 0.89% 0.88% 0.92% 0.87% 0.43% 0.09% 0.08% 0.00% 0.00%
57.66% 58.78% 59.07% 60.52% 60.43% 60.99% 60.54% 60.65% 60.79% 60.80% 61.44% 61.72%
No. of Shareholders 34,53942,49743,10644,30245,84848,59849,05050,46050,02248,18949,01748,077

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls